Immune cell cryopreservation liquid, and preparation method, cryopreservation method and application thereof

A technology of immune cells and cryopreservation method, applied in the field of cell preservation, can solve the problems of reducing the possibility of animal pathogen contamination, low survival rate of immune cells in frozen liquid, etc., to protect from freezing damage, maintain physiological functions and biological functions , Good freezing effect

CN107787959AInactive Publication Date: 2018-03-13广州市金航生物科技有限公司
4 Cites 10 Cited by

Patent Information

Authority / Receiving Office
CN · China
Current Assignee / Owner
Publication Date
2018-03-13
Estimated Expiration
Not applicable · inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The invention discloses an immune cell cryopreservation liquid, and a preparation method, a cryopreservation method and an application thereof; the immune cell cryopreservation liquid includes the components by weight: 5%-15% of DMSO, 1%-5% of propylene glycol, 2%-8% of trehalose, 3%-8% of methyl cellulose, 0.3%-1.2% of glutathione, 0.06%-0.14% of sodium pyruvate, and 60%-80% of human donor plasma; the cryopreservation effect is quite good, the immune cells can be effectively protected from freezing injury, physiological functions and biological characteristics of the immune cells after resuscitation are maintained, cell biological characteristics are not changed, and the immune cell cryopreservation liquid can be used in clinical treatment; the immune cell cryopreservation liquid is suitable for long-term frozen preservation of human mononuclear cells and other kinds of immune cells.
Need to check novelty before this filing date? Find Prior Art

Description

technical field

[0001] The invention belongs to the technical field of cell preservation, and in particular relates to an immune cell cryopreservation solution, its preparation method, cryopreservation method and application. Background technique

[0002] In recent years, immunotherapy techniques for tumors and viruses have been gradually applied clinically. Such as tumor vaccines and adoptive immunotherapy, these methods mainly improve the immunity of patients through in vitro stimulation, culture, expansion and reinfusion of autologous immune cells. At present, such cells mainly include dendritic cells (DC), cells Factor-induced killer cells (CIK), natural killer cells (NK), dendritic cell-induced killer cells (DC-CIK), chimeric antigen receptor T cells (CAR-T), etc. The initial cell sources of these induced and expanded immune cells are mononuclear cells from peripheral blood or umbilical cord blood, and they are directly isolated and cultured.

[0003] As the age incre...

Examples

Embodiment 1

[0027] Embodiment 1 The composition of immune cell cryopreservation liquid

[0028] By weight: 5% DMSO, 8% propylene glycol, 6% trehalose, 8% methylcellulose, 0.3% glutathione, 0.06% sodium pyruvate, 72.64% human donor plasma.

Embodiment 2

[0029] Example 2 Composition of Immune Cell Cryopreservation Solution

[0030] By weight: 12% DMSO, 4% propylene glycol, 6% trehalose, 7% methylcellulose, 1% glutathione, 0.12% sodium pyruvate, 69.88% human donor plasma.

Embodiment 3

[0031] Example 3 Composition of Immune Cell Cryopreservation Solution

[0032] By weight: 10% DMSO, 3% propylene glycol, 5% trehalose, 6% methylcellulose, 0.8% glutathione, 0.1% sodium pyruvate, 75.1% human donor plasma.